Articles
11.11.2026
 JCA as a governance challenge: Aligning global, ...

Given the overlap in Joint Clinical Assessment (JCA) and national-level HTA timelines, manufacturers...

Read more
Poster
11.11.2026
Will the new National HealthTech Access Programme ...

Introduction Announced in the 2025 NHS 10-year plan, the National HealthTech Access Programme (NHAP)...

Read more
Poster
11.11.2026
Identifying patterns in lung cancer Health Technol...

Introduction Understanding differences in HTA outcomes across markets remains challenging due to var...

Read more
Poster
11.11.2026
Are AI-based digital twins entering HTA? A review ...

Introduction Digital twins are dynamic digital representations that combine patient-specific multidi...

Read more
Poster
11.11.2026
How have NICE committees applied the new cost-effe...

Introduction Authors: Sam Bean BSc, MSc; Solen Monteil PhD Objectives Conclusions

Read more
Poster
11.11.2026
Assessing European reimbursement friction and priv...

Introduction European public healthcare systems are facing increasing budget pressure, driven by pos...

Read more
Poster
11.11.2026
Can national Early Scientific Advice support JCA r...

Introduction A Joint Scientific Consultation (JSC) has been established to provide advice on evidenc...

Read more
Poster
11.11.2026
How national HTA systems are being reshaped in res...

Introduction The EU Health Technology Assessment (HTA) Regulation (EU 2021/2282) introduced Joint Cl...

Read more
Webinar
05.11.2026
PICO Planning for HTA | On-Demand Webinar | Remap

Predicting PICO requirements can help pharmaceutical manufacturers anticipate the populations, compa...

Read more
Articles
02.11.2026
JCA Evidence Gaps: Meeting National Payer Needs

Introduction The EU Joint Clinical Assessment (JCA) was introduced to reduce duplication and establi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.